Domenico Petta
Chief Executive Officer at S.A. 4M Europe SA
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Eric Feller | M | - |
Targetome NV
 Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 14 years |
| Joseph Martial | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 years |
| Daniel Marechal | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 8 years |
| Francesco Fornieri | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 11 years |
| John Kelly | M | - |
Targetome NV
Targetome NV Pharmaceuticals: MajorHealth Technology Targetome SA operates is a biotech company which develops affinity-based targeted therapies against unmet medical needs with initial focus on pancreatic cancer and liver metastases. The firm develops antibody-drug conjugates. The company was founded by Edwin de Pauw and Vincent Castronovo in 2010 and is headquartered in Liege, Belgium. | 9 years |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Belgium | 5 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Domenico Petta
- Personal Network
